Trending stocks today
Carl Zeiss Meditec (AFX-O)
0.00
Financials
Technical Analysis
Buy, Sell or Hold?
This summary was created by AI, based on 1 opinions in the last 12 months.
Carl Zeiss Meditec, symbol AFX-O, is a German company that manufactures lenses for microscopes used by surgeons, as well as mirrors for ASML. The company also produces laser surgery equipment and is considered an asset-lite company with substantial cash reserves. However, the stock has experienced a decline from 150 Euros due to slowing sales in China and North America. The current price target is 83.58 Euros, and the stock trades at 13x PE 2026. Experts believe that if interest rates decline, the company will benefit. Overall, the company faces challenges in its key markets but is well-positioned for future growth.
N/A
Owned
- «
- ‹
- 1
- ›
- »
Carl Zeiss Meditec(AFX-O) Rating
Ranking : 1 out of 5
Bullish - Buy Signals / Votes : 0
Neutral - Hold Signals / Votes : 0
Bearish - Sell Signals / Votes : 0
Total Signals / Votes : 0
Carl Zeiss Meditec(AFX-O) Frequently Asked Questions
What is Carl Zeiss Meditec stock symbol?
Carl Zeiss Meditec is a OTC stock, trading under the symbol AFX-O on the (). It is usually referred to as or AFX-O
Is Carl Zeiss Meditec a buy or a sell?
In the last year, there was no coverage of Carl Zeiss Meditec published on Stockchase.
Is Carl Zeiss Meditec a good investment or a top pick?
Carl Zeiss Meditec was recommended as a Top Pick by on . Read the latest stock experts ratings for Carl Zeiss Meditec.
Why is Carl Zeiss Meditec stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
Is Carl Zeiss Meditec worth watching?
In the last year 0 stock analysts on Stockchase covered Carl Zeiss Meditec. The stock is worth watching.
What is Carl Zeiss Meditec stock price?
On , Carl Zeiss Meditec (AFX-O) stock closed at a price of $.
They make lenses for microscopes used by surgeons, and mirrors for ASML. Share are down from 150 Euros due to slowing sales in China and North America. They also make laser surgery equipment. But it's an asset-lite company with tons of cash. It trades at 13x PE 2026. If interest rate decline, they will benefit.